Mergers and Acquisitions:
Plan your Exit Strategy
Tuesday, April 29, 2008
6:30 pm - 9:00 pm
Open only to Bioscience Industry Executives and Entrepreneurs.
As an executive in the Bioscience/Pharmaceutical industry, you are familiar with mergers and
acquisitions occurring in our environment daily. However, what are the implications of such an exit
strategy from the points of view of each side of the transaction? Can this be an acceptable future
strategy for your own company? This program helped to answer those questions and provided perspectives
on the hard and soft issues surrounding this approach.
Distinguished Panelists included (in alphabetical order):
- Stephanie Fiesta, Attorney, Wilmer Hale (Transactional expert)
- Sandra Retzky, VP of Licensing, Wyeth (Acquisition expert)
- Deborah Stewart, Managing Director, Invotex (Valuation expert)
- Cheri Walker, Sr VP Corp Development, Charles Rivers Labs (Acquisition expert)
Toucan Capital Corp.
7600 Wisconsin Avenue
7th Floor
Bethesda, MD 20814
www.toucancapital.com
Click here for a map to the event.
*Located in the heart of downtown Bethesda, Maryland, one block from the Bethesda Metro subway stop and less than a mile from the
National Institutes of Health.
6:30 pm to 7:00 pm - Registration and networking reception
7:00 pm to 9:00 pm - Program
This program was open only to bioscience industry executives and entrepreneurs.
For information, contact
or
Not a member? Join today and we will see you at the event.
|
